| Similar Articles |
|---|
 |
The Motley Fool
October 16, 2008
Brian Orelli |
Foolish Forecast: Robots on the Cheap Intuitive Surgical releases earnings in a few hours. Here are some premonitions to tide you over as you anxiously wait the news.   |
The Motley Fool
November 28, 2008
Brian Orelli |
Bargain Stocks for Black Friday: Intuitive Surgical This is a company that's seen trailing-12-month revenue increase 59% year over year. No matter what you think of high-growth stocks, its 25 P/E is pretty darn cheap. |
The Motley Fool
August 24, 2010
Brian Orelli |
Disaster in Medical-Device Land Industry bellwether Medtronic is forecasting a nasty storm. |
The Motley Fool
October 18, 2010
Anand Chokkavelu |
There Are Better Opportunities Than Boston Scientific Let's take a look. By the numbers, Abbott, Medtronic, and Johnson & Johnson all look more compelling than Boston Scientific. |
The Motley Fool
April 17, 2008
Anders Bylund |
Foolish Forecast: Intuitive Surgical Is Worth Every Penny In advance of earnings, let's compare robotic-surgery equipment manufacturer Intuitive Surgical to some of its peers and competitors. |
The Motley Fool
October 19, 2011
Brian Orelli |
This High-Tech Company Still Has the Touch Intuitive Surgical beats analysts' expectations. Again. |
The Motley Fool
July 20, 2010
Jim Mueller |
Buy, Sell, or Hold Intuitive Surgical? Coming into the quarterly earnings, what should investors do regarding Intuitive Surgical? Here's a quick look at some arguments for the three possibilities. |
The Motley Fool
February 8, 2011
Brian Orelli |
What Will Intuitive Surgical Do for an Encore? Intuitive Surgical managed just a 10% year-over-year increase in revenue from sales of its da Vinci Surgical Systems in the fourth quarter of last year. Yet its total revenue increased a solid 21%. How? |
The Motley Fool
May 19, 2009
Brian Orelli |
Medtronic Gets Whacked, Seeks Recovery Device Medtronic gets hammered on lackluster guidance. |
The Motley Fool
October 17, 2008
Brian Orelli |
Shareholders Slap Stryker A little earnings miss sends the medical technology company down more than necessary. |
The Motley Fool
February 3, 2006
Stephen D. Simpson |
Phase 2 for Intuitive Surgical Now that the initial rush is over, it's time for Intuitive Surgical to build a lasting business. Investors need to be careful with this one. |
The Motley Fool
December 30, 2009
Brian Orelli |
The Best Stocks for 2010: Intuitive Surgical Intuitive Surgical never looks cheap. Then again, good growth stocks usually don't. |
The Motley Fool
July 22, 2010
Brian Orelli |
One Surgery Dominated, A Hundred More to Go Intuitive Surgical isn't slowing down. |
The Motley Fool
January 23, 2009
Brian Orelli |
Intuitive Surgical Is Taking Cues From Warren Buffett Even with the paltry projected growth predicted in the short-term, Intuitive Surgical looks like a good long-term investment. |
The Motley Fool
November 18, 2008
Brian Orelli |
No Buffer for Medtronic Even though sales grew for the quarter, investors weren't happy. |
The Motley Fool
July 25, 2007
Billy Fisher |
Dueling Fools: Intuitive Surgical Bull Rebuttal On the bull side, experience, coupled with the company's future earnings and revenue prospects, may indicate that Intuitive Surgical has yet to reach its zenith. |
The Motley Fool
January 8, 2009
Brian Orelli |
Lowered Guidance? No Problem! Investors with long-term horizons will likely see this downturn as a small blip on the general upward trend of Intuitive Surgical. |
The Motley Fool
November 11, 2009
Jim Mueller |
This Company Is a Value Stock! Isn't It? A look at Boston Scientific leads to conflicting conclusions. |
The Motley Fool
July 17, 2008
Brian Orelli |
Investors Yawn at Abbott Labs' Growth Abbott Labs may be firing on all cylinders, but investors were less than impressed with its earnings release |
The Motley Fool
June 24, 2009
Brian Orelli |
Boston Scientific Helps Itself ... and Its Rivals Boston Scientific released positive results from a clinical trial testing its heart devices, but unfortunately the data is likely to help its competitors as well. |
The Motley Fool
August 29, 2010
Jeremy Phillips |
Is Trouble Ahead for Intuitive Surgical? Does this highly-shorted stock deserve it? |
The Motley Fool
January 20, 2009
Anders Bylund |
Foolish Forecast: Grab Intuitive Surgical While It's Cheap In advance of earnings let's take a look at how medical robotics maker Intuitive Surgical stacks up against some of its peers and competitors. |
The Motley Fool
May 25, 2010
Brian Orelli |
Medtronic Gets Tossed Out With the Bathwater A bad day to report good news. |
The Motley Fool
April 15, 2009
Brian Orelli |
Abbott's on Sale Abbott isn't firing on all cylinders the way it was last year, but things still look fine, and the stock is selling at a discount right now. |
The Motley Fool
October 21, 2009
Brian Orelli |
Slicing and Dicing Intuitive Surgical's Quarter Not the best we've seen, but still solid. |
The Motley Fool
August 25, 2009
Brian Orelli |
Medtronic Takes the Road Less Traveled It looks like this medical devices company is healthy again. |
The Motley Fool
August 18, 2008
Brian Orelli |
Foolish Forecast: Taking Medtronic to Heart In advance of earnings analysts expect Medtronic, with another medical device approval, to boost revenues 17%. |
The Motley Fool
March 6, 2009
Brian Orelli |
Why the Buyback, Intuitive Surgical? Buybacks for high-growth companies like Intuitive Surgical aren't such a bad idea anymore. |
The Motley Fool
February 24, 2010
Brian Orelli |
Medtronic Needs to Regrow a Spine Everything else looks fairly good, but the problem I see involves the slight decline in Medtronic's second-largest segment, spinal products. |
The Motley Fool
December 3, 2010
Seth Jayson |
How Boston Scientific May Be Failing You With recent TTM margins all well below historical averages, Boston Scientific has some work to do. |
The Motley Fool
April 17, 2009
Brian Orelli |
Intuitively Waiting Systems sales are down; no surprise there. |
The Motley Fool
January 29, 2009
Brian Orelli |
No Buyer's Remorse at Boston Scientific The pacemakers and defibrillators that Guidant contributed to Boston Scientific's bottom line are still growing strong, but the company had to take a whopping $2.7 billion goodwill writedown because the value of what it purchased has changed. |
The Motley Fool
April 28, 2006
Stephen D. Simpson |
Of Intuition and Intuitive Surgical Price has decoupled from value, but the company is growing like a weed. Investors, take note. |
The Motley Fool
February 12, 2010
Brian Orelli |
Too Bad It's Not in the "Restructuring" Business Shares of Boston Scientific slipped nearly 10% yesterday, after the company released earnings and guidance for this year. |
The Motley Fool
April 22, 2005
Stephen D. Simpson |
Success Is Intuitive Surgical robotics continues to grow, and Intuitive Surgical dominates the market. It's important to note, though, that valuation is a tricky matter when you're dealing with fast-growing companies that are basically pioneering entirely new businesses. |
The Motley Fool
February 1, 2010
Brian Orelli |
Now That's Some Expensive Risk Mitigation Boston Scientific avoids a trial -- but at a dear cost. |
The Motley Fool
July 27, 2006
Stephen D. Simpson |
Growth Ingrates Dump Intuitive Surgical Despite today's sell-off, Intuitive Surgical remains a red-hot grower in the med-tech space. |
The Motley Fool
February 17, 2009
Brian Orelli |
Investors Heart Medtronic The leaner company is more lovable. |
The Motley Fool
November 24, 2009
Brian Orelli |
52-Week Highs! What's Going On? Even with its recent leap, this stock may belong in your portfolio. Medtronic raised earnings guidance today after a fairly strong quarter, and the stock is hitting new 52-week highs. |
The Motley Fool
January 10, 2008
Mac Greer |
Fool Video: The Future of Baidu and Intuitive Surgical How will Baidu and Intuitive Surgical perform in 2008? Could Google have its eyes on Baidu? Could Johnson & Johnson have its sights on Intuitive Surgical? These questions are discussed in this video. |
The Motley Fool
October 20, 2009
Robert Steyer |
The Heart Company's Disheartening Forecast Boston Scientific scaled back its full-year forecast, and the market doesn't like it. |
The Motley Fool
October 13, 2008
Brian Orelli |
Too Little Too Late for Boston Scientific The company gets new stent approved, but it should have happened earlier. |
The Motley Fool
April 21, 2009
Brian Orelli |
Boston Scientific Rebuilds Whether the company is a value or a value trap depends on how well the rebuilding goes this year. |
The Motley Fool
February 3, 2011
Brian Orelli |
Add This Stock to Your Show-Me List Wait for the turnaround before investing in Boston Scientific; if it ever comes. |
The Motley Fool
June 4, 2010
Jim Mueller |
The Changing Face of Abbott Abbott Labs' shift in revenue sources has been a boon over the last five years. |
The Motley Fool
May 29, 2008
Brian Orelli |
Medtronic Sticks It to Boston Scientific Medtronic wins the medical-device patent duel with Boston Scientific. |
The Motley Fool
June 4, 2010
Brian Richards |
Intuitive Surgical: Strengths, Weaknesses, Opportunities, Threats A look inside the business of the da Vinci robot maker. |
The Motley Fool
November 3, 2008
Brian Orelli |
Quality Growth From Quality Systems Revenue from the health-care software systems provider Quality Systems rose 31% over the year-ago quarter, but the bottom line is dragging for now. |
The Motley Fool
January 28, 2009
Brian Orelli |
The Streak Is Over After 31 consecutive quarters of double-digit sales growth, medical device maker Stryker finally had an off quarter. |
The Motley Fool
June 26, 2009
Brian Orelli |
Change at Top Looks Good for Bottom Line Investors welcome Boston Scientific's new boss. |
